Home

bitte nicht Bowling Bombe lonza fill finish Archäologisch Extremisten verhindern

Lonza Plans New Fill & Finish Facility in Stein, Switzerland
Lonza Plans New Fill & Finish Facility in Stein, Switzerland

Lonza adds a commercial filling line - BioProcess InsiderBioProcess  International
Lonza adds a commercial filling line - BioProcess InsiderBioProcess International

Lonza on target with Moderna COVID vaccine production in Portsmouth
Lonza on target with Moderna COVID vaccine production in Portsmouth

On a roll, Moderna taps Thermo Fisher for fill-finish duties and Lonza for  booster shot manufacturing | Fierce Pharma
On a roll, Moderna taps Thermo Fisher for fill-finish duties and Lonza for booster shot manufacturing | Fierce Pharma

Lonza on LinkedIn: Automation and AI Help Meet Demand for Biologics Fill- Finish Services
Lonza on LinkedIn: Automation and AI Help Meet Demand for Biologics Fill- Finish Services

Lonza to invest $500 million in a fill and finish plant for biologic drugs
Lonza to invest $500 million in a fill and finish plant for biologic drugs

Taking a lifecycle approach to fill-finish success
Taking a lifecycle approach to fill-finish success

Lonza and Vertex to build 'ground-breaking' cell therapy manufacturing  facility
Lonza and Vertex to build 'ground-breaking' cell therapy manufacturing facility

Exclusive: Manufacturer Lonza says it will not fill obesity drug syringes |  Reuters
Exclusive: Manufacturer Lonza says it will not fill obesity drug syringes | Reuters

Lonza ups HPAPI manufacturing in China with new cGMP space
Lonza ups HPAPI manufacturing in China with new cGMP space

We are expanding our drug product manufacturing network in Switzerland.  This will include the installation of a new aseptic fill and finish line in  Stein... | By Lonza Group | Facebook
We are expanding our drug product manufacturing network in Switzerland. This will include the installation of a new aseptic fill and finish line in Stein... | By Lonza Group | Facebook

Lonza erweitert Biokonjugationsanlage in Visp
Lonza erweitert Biokonjugationsanlage in Visp

Lonza to build new $518M large-scale, fill-finish facility
Lonza to build new $518M large-scale, fill-finish facility

Lonza Expands Operations In China | Contract Pharma
Lonza Expands Operations In China | Contract Pharma

Lonza Agrees to Acquire Sterile Fill and Finish Facility from Novartis
Lonza Agrees to Acquire Sterile Fill and Finish Facility from Novartis

Lonza to Sell Two Production Sites to Nextpharma
Lonza to Sell Two Production Sites to Nextpharma

Focus on Fill and Finish
Focus on Fill and Finish

Hochrhein/Schweiz: Kommt bald noch mehr Impfstoff aus dem Fricktal? Lonza  will in Stein erweitern und 70 Arbeitsplätze schaffen | SÜDKURIER
Hochrhein/Schweiz: Kommt bald noch mehr Impfstoff aus dem Fricktal? Lonza will in Stein erweitern und 70 Arbeitsplätze schaffen | SÜDKURIER

Lonza To Establish Large-Scale, Commercial Drug Product Fill & Finish  Facility in Stein (CH) | Technology Networks
Lonza To Establish Large-Scale, Commercial Drug Product Fill & Finish Facility in Stein (CH) | Technology Networks

Lonza und Vertex bauen Anlage für neue Diabetes-Zelltherapien
Lonza und Vertex bauen Anlage für neue Diabetes-Zelltherapien

Lonza Completes Tampa Expansion | CHEManager
Lonza Completes Tampa Expansion | CHEManager

Pharma giant Lonza begins work on another expansion at Pease campus - NH  Business Review
Pharma giant Lonza begins work on another expansion at Pease campus - NH Business Review

Lonza snaps up Novartis fill-and-finish facility to expand offering |  Euronews
Lonza snaps up Novartis fill-and-finish facility to expand offering | Euronews

Lonza purchases Novartis' sterile fill-finish site
Lonza purchases Novartis' sterile fill-finish site

Lonza baut neue Abfüllanlage in Stein | S-GE
Lonza baut neue Abfüllanlage in Stein | S-GE

Lonza to expand bioconjugation capabilities at Visp site
Lonza to expand bioconjugation capabilities at Visp site

Lonza Expands its Bioconjugation Facility with Two Additional Manufacturing  Suites and Significantly Increases Process and Analytical Development  Capacity » ADC Review
Lonza Expands its Bioconjugation Facility with Two Additional Manufacturing Suites and Significantly Increases Process and Analytical Development Capacity » ADC Review